These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20564203)

  • 1. Ferroportin1 and hephaestin overexpression attenuate iron-induced oxidative stress in MES23.5 dopaminergic cells.
    Song N; Wang J; Jiang H; Xie J
    J Cell Biochem; 2010 Aug; 110(5):1063-72. PubMed ID: 20564203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease.
    Song N; Wang J; Jiang H; Xie J
    Free Radic Biol Med; 2010 Jan; 48(2):332-41. PubMed ID: 19913091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats.
    Wang J; Jiang H; Xie JX
    Eur J Neurosci; 2007 May; 25(9):2766-72. PubMed ID: 17561842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent.
    Jiang H; Song N; Xu H; Zhang S; Wang J; Xie J
    Cell Res; 2010 Mar; 20(3):345-56. PubMed ID: 20125122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells.
    Xu HM; Jiang H; Wang J; Luo B; Xie JX
    Neurochem Int; 2008 May; 52(6):1044-51. PubMed ID: 18082289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells.
    Zhang S; Wang J; Song N; Xie J; Jiang H
    Neurobiol Aging; 2009 Sep; 30(9):1466-76. PubMed ID: 18191877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron transport in Parkinson's disease.
    Hirsch EC
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1.
    Aguirre P; Urrutia P; Tapia V; Villa M; Paris I; Segura-Aguilar J; Núñez MT
    Biometals; 2012 Aug; 25(4):795-803. PubMed ID: 22302610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ndfip1 attenuated 6-OHDA-induced iron accumulation via regulating the degradation of DMT1.
    Jia W; Xu H; Du X; Jiang H; Xie J
    Neurobiol Aging; 2015 Feb; 36(2):1183-93. PubMed ID: 25467637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High hepcidin level accounts for the nigral iron accumulation in acute peripheral iron intoxication rats.
    Sun C; Song N; Xie A; Xie J; Jiang H
    Toxicol Lett; 2012 Aug; 212(3):276-81. PubMed ID: 22659129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroportin 1 and hephaestin expression in BeWo cell line with different iron treatment.
    Li YQ; Bai B; Cao XX; Yan H; Zhuang GH
    Cell Biochem Funct; 2012 Apr; 30(3):249-55. PubMed ID: 22170436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen/nitrogen species production in ventral mesencephalic neurons.
    Wang J; Song N; Jiang H; Wang J; Xie J
    Biochim Biophys Acta; 2013 May; 1832(5):618-25. PubMed ID: 23376588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rg1 protects iron-induced neurotoxicity through antioxidant and iron regulatory proteins in 6-OHDA-treated MES23.5 cells.
    Xu H; Jiang H; Wang J; Xie J
    J Cell Biochem; 2010 Dec; 111(6):1537-45. PubMed ID: 20872781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible role of iron in the etiopathology of Parkinson's disease.
    Youdim MB; Ben-Shachar D; Riederer P
    Mov Disord; 1993; 8(1):1-12. PubMed ID: 8419792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models.
    Kim HG; Ju MS; Shim JS; Kim MC; Lee SH; Huh Y; Kim SY; Oh MS
    Br J Nutr; 2010 Jul; 104(1):8-16. PubMed ID: 20187987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of iron in senescence of dopaminergic neurons in Parkinson's disease.
    Youdim MB; Riederer P
    J Neural Transm Suppl; 1993; 40():57-67. PubMed ID: 8294901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes.
    Ge XH; Wang Q; Qian ZM; Zhu L; Du F; Yung WH; Yang L; Ke Y
    J Nutr Biochem; 2009 Nov; 20(11):860-5. PubMed ID: 19027283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of xyloketal B against MPP+-induced neurotoxicity in Caenorhabditis elegans and PC12 cells.
    Lu XL; Yao XL; Liu Z; Zhang H; Li W; Li Z; Wang GL; Pang J; Lin Y; Xu Z; Chen L; Pei Z; Zeng J
    Brain Res; 2010 May; 1332():110-9. PubMed ID: 20347725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells.
    Wang J; Du XX; Jiang H; Xie JX
    Biochem Pharmacol; 2009 Jul; 78(2):178-83. PubMed ID: 19464433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron metabolism and Parkinson's disease.
    Hirsch EC; Faucheux BA
    Mov Disord; 1998; 13 Suppl 1():39-45. PubMed ID: 9613717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.